Vericel Corporation (VCEL)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$40.00+$0.7000 (+1.78%) on the dayAs of the close; data may be delayed.
VCEL price, last 12 months
Key stats
- Previous close
- $39.30
- Open
- $39.30
- Day range
- $38.74 – $40.51
- 52-week range
- $28.95 – $49.32
- Volume
- 258.8K
- Avg volume (20 days)
- 492K
- Market cap
- $2.0B
Performance
1W−0.1%
1M−5.8%
3M−13.5%
6M+29.8%
YTD+11.1%
1Y+32.2%
vs S&P 500, 1Y+15.5 pts
Technicals and fundamentals
About Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $2.0B